Your payment is in progress...
  +1 (704) 266-3234

Global Nanotechnology For Healthcare Market Size, Status And Forecast 2020-2026

Published on: Jun 2020 | From USD $3900 | Published By: QY RESEARCH | Number Of Pages: 134

This report focuses on the global Nanotechnology for Healthcare status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Nanotechnology for Healthcare development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Amgen
Teva Pharmaceuticals
Abbott
UCB
Roche
Celgene
Sanofi
Merck & Co
Biogen
Stryker
Gilead Sciences
Pfizer
3M Company
Johnson & Johnson
Smith & Nephew
Leadiant Biosciences
Kyowa Hakko Kirin
Shire
Ipsen
Endo International

Market segment by Type, the product can be split into
Nanomedicine
Nano Medical Devices
Nano Diagnosis
Other
Market segment by Application, split into
Anticancer
CNS Product
Anti-infective
Other

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Nanotechnology for Healthcare status, future forecast, growth opportunity, key market and key players.
To present the Nanotechnology for Healthcare development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Nanotechnology for Healthcare are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Nanotechnology for Healthcare Revenue
1.4 Market Analysis by Type
1.4.1 Global Nanotechnology for Healthcare Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Nanomedicine
1.4.3 Nano Medical Devices
1.4.4 Nano Diagnosis
1.4.5 Other
1.5 Market by Application
1.5.1 Global Nanotechnology for Healthcare Market Share by Application: 2020 VS 2026
1.5.2 Anticancer
1.5.3 CNS Product
1.5.4 Anti-infective
1.5.5 Other
1.6 Coronavirus Disease 2019 (Covid-19): Nanotechnology for Healthcare Industry Impact
1.6.1 How the Covid-19 is Affecting the Nanotechnology for Healthcare Industry
1.6.1.1 Nanotechnology for Healthcare Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Nanotechnology for Healthcare Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Nanotechnology for Healthcare Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 Global Growth Trends by Regions
2.1 Nanotechnology for Healthcare Market Perspective (2015-2026)
2.2 Nanotechnology for Healthcare Growth Trends by Regions
2.2.1 Nanotechnology for Healthcare Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Nanotechnology for Healthcare Historic Market Share by Regions (2015-2020)
2.2.3 Nanotechnology for Healthcare Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Nanotechnology for Healthcare Market Growth Strategy
2.3.6 Primary Interviews with Key Nanotechnology for Healthcare Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Nanotechnology for Healthcare Players by Market Size
3.1.1 Global Top Nanotechnology for Healthcare Players by Revenue (2015-2020)
3.1.2 Global Nanotechnology for Healthcare Revenue Market Share by Players (2015-2020)
3.1.3 Global Nanotechnology for Healthcare Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Nanotechnology for Healthcare Market Concentration Ratio
3.2.1 Global Nanotechnology for Healthcare Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Nanotechnology for Healthcare Revenue in 2019
3.3 Nanotechnology for Healthcare Key Players Head office and Area Served
3.4 Key Players Nanotechnology for Healthcare Product Solution and Service
3.5 Date of Enter into Nanotechnology for Healthcare Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)
4.1 Global Nanotechnology for Healthcare Historic Market Size by Type (2015-2020)
4.2 Global Nanotechnology for Healthcare Forecasted Market Size by Type (2021-2026)

5 Nanotechnology for Healthcare Breakdown Data by Application (2015-2026)
5.1 Global Nanotechnology for Healthcare Market Size by Application (2015-2020)
5.2 Global Nanotechnology for Healthcare Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Nanotechnology for Healthcare Market Size (2015-2020)
6.2 Nanotechnology for Healthcare Key Players in North America (2019-2020)
6.3 North America Nanotechnology for Healthcare Market Size by Type (2015-2020)
6.4 North America Nanotechnology for Healthcare Market Size by Application (2015-2020)

7 Europe
7.1 Europe Nanotechnology for Healthcare Market Size (2015-2020)
7.2 Nanotechnology for Healthcare Key Players in Europe (2019-2020)
7.3 Europe Nanotechnology for Healthcare Market Size by Type (2015-2020)
7.4 Europe Nanotechnology for Healthcare Market Size by Application (2015-2020)

8 China
8.1 China Nanotechnology for Healthcare Market Size (2015-2020)
8.2 Nanotechnology for Healthcare Key Players in China (2019-2020)
8.3 China Nanotechnology for Healthcare Market Size by Type (2015-2020)
8.4 China Nanotechnology for Healthcare Market Size by Application (2015-2020)

9 Japan
9.1 Japan Nanotechnology for Healthcare Market Size (2015-2020)
9.2 Nanotechnology for Healthcare Key Players in Japan (2019-2020)
9.3 Japan Nanotechnology for Healthcare Market Size by Type (2015-2020)
9.4 Japan Nanotechnology for Healthcare Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Nanotechnology for Healthcare Market Size (2015-2020)
10.2 Nanotechnology for Healthcare Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Nanotechnology for Healthcare Market Size by Type (2015-2020)
10.4 Southeast Asia Nanotechnology for Healthcare Market Size by Application (2015-2020)

11 India
11.1 India Nanotechnology for Healthcare Market Size (2015-2020)
11.2 Nanotechnology for Healthcare Key Players in India (2019-2020)
11.3 India Nanotechnology for Healthcare Market Size by Type (2015-2020)
11.4 India Nanotechnology for Healthcare Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Nanotechnology for Healthcare Market Size (2015-2020)
12.2 Nanotechnology for Healthcare Key Players in Central & South America (2019-2020)
12.3 Central & South America Nanotechnology for Healthcare Market Size by Type (2015-2020)
12.4 Central & South America Nanotechnology for Healthcare Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Amgen
13.1.1 Amgen Company Details
13.1.2 Amgen Business Overview and Its Total Revenue
13.1.3 Amgen Nanotechnology for Healthcare Introduction
13.1.4 Amgen Revenue in Nanotechnology for Healthcare Business (2015-2020))
13.1.5 Amgen Recent Development
13.2 Teva Pharmaceuticals
13.2.1 Teva Pharmaceuticals Company Details
13.2.2 Teva Pharmaceuticals Business Overview and Its Total Revenue
13.2.3 Teva Pharmaceuticals Nanotechnology for Healthcare Introduction
13.2.4 Teva Pharmaceuticals Revenue in Nanotechnology for Healthcare Business (2015-2020)
13.2.5 Teva Pharmaceuticals Recent Development
13.3 Abbott
13.3.1 Abbott Company Details
13.3.2 Abbott Business Overview and Its Total Revenue
13.3.3 Abbott Nanotechnology for Healthcare Introduction
13.3.4 Abbott Revenue in Nanotechnology for Healthcare Business (2015-2020)
13.3.5 Abbott Recent Development
13.4 UCB
13.4.1 UCB Company Details
13.4.2 UCB Business Overview and Its Total Revenue
13.4.3 UCB Nanotechnology for Healthcare Introduction
13.4.4 UCB Revenue in Nanotechnology for Healthcare Business (2015-2020)
13.4.5 UCB Recent Development
13.5 Roche
13.5.1 Roche Company Details
13.5.2 Roche Business Overview and Its Total Revenue
13.5.3 Roche Nanotechnology for Healthcare Introduction
13.5.4 Roche Revenue in Nanotechnology for Healthcare Business (2015-2020)
13.5.5 Roche Recent Development
13.6 Celgene
13.6.1 Celgene Company Details
13.6.2 Celgene Business Overview and Its Total Revenue
13.6.3 Celgene Nanotechnology for Healthcare Introduction
13.6.4 Celgene Revenue in Nanotechnology for Healthcare Business (2015-2020)
13.6.5 Celgene Recent Development
13.7 Sanofi
13.7.1 Sanofi Company Details
13.7.2 Sanofi Business Overview and Its Total Revenue
13.7.3 Sanofi Nanotechnology for Healthcare Introduction
13.7.4 Sanofi Revenue in Nanotechnology for Healthcare Business (2015-2020)
13.7.5 Sanofi Recent Development
13.8 Merck & Co
13.8.1 Merck & Co Company Details
13.8.2 Merck & Co Business Overview and Its Total Revenue
13.8.3 Merck & Co Nanotechnology for Healthcare Introduction
13.8.4 Merck & Co Revenue in Nanotechnology for Healthcare Business (2015-2020)
13.8.5 Merck & Co Recent Development
13.9 Biogen
13.9.1 Biogen Company Details
13.9.2 Biogen Business Overview and Its Total Revenue
13.9.3 Biogen Nanotechnology for Healthcare Introduction
13.9.4 Biogen Revenue in Nanotechnology for Healthcare Business (2015-2020)
13.9.5 Biogen Recent Development
13.10 Stryker
13.10.1 Stryker Company Details
13.10.2 Stryker Business Overview and Its Total Revenue
13.10.3 Stryker Nanotechnology for Healthcare Introduction
13.10.4 Stryker Revenue in Nanotechnology for Healthcare Business (2015-2020)
13.10.5 Stryker Recent Development
13.11 Gilead Sciences
10.11.1 Gilead Sciences Company Details
10.11.2 Gilead Sciences Business Overview and Its Total Revenue
10.11.3 Gilead Sciences Nanotechnology for Healthcare Introduction
10.11.4 Gilead Sciences Revenue in Nanotechnology for Healthcare Business (2015-2020)
10.11.5 Gilead Sciences Recent Development
13.12 Pfizer
10.12.1 Pfizer Company Details
10.12.2 Pfizer Business Overview and Its Total Revenue
10.12.3 Pfizer Nanotechnology for Healthcare Introduction
10.12.4 Pfizer Revenue in Nanotechnology for Healthcare Business (2015-2020)
10.12.5 Pfizer Recent Development
13.13 3M Company
10.13.1 3M Company Company Details
10.13.2 3M Company Business Overview and Its Total Revenue
10.13.3 3M Company Nanotechnology for Healthcare Introduction
10.13.4 3M Company Revenue in Nanotechnology for Healthcare Business (2015-2020)
10.13.5 3M Company Recent Development
13.14 Johnson & Johnson
10.14.1 Johnson & Johnson Company Details
10.14.2 Johnson & Johnson Business Overview and Its Total Revenue
10.14.3 Johnson & Johnson Nanotechnology for Healthcare Introduction
10.14.4 Johnson & Johnson Revenue in Nanotechnology for Healthcare Business (2015-2020)
10.14.5 Johnson & Johnson Recent Development
13.15 Smith & Nephew
10.15.1 Smith & Nephew Company Details
10.15.2 Smith & Nephew Business Overview and Its Total Revenue
10.15.3 Smith & Nephew Nanotechnology for Healthcare Introduction
10.15.4 Smith & Nephew Revenue in Nanotechnology for Healthcare Business (2015-2020)
10.15.5 Smith & Nephew Recent Development
13.16 Leadiant Biosciences
10.16.1 Leadiant Biosciences Company Details
10.16.2 Leadiant Biosciences Business Overview and Its Total Revenue
10.16.3 Leadiant Biosciences Nanotechnology for Healthcare Introduction
10.16.4 Leadiant Biosciences Revenue in Nanotechnology for Healthcare Business (2015-2020)
10.16.5 Leadiant Biosciences Recent Development
13.17 Kyowa Hakko Kirin
10.17.1 Kyowa Hakko Kirin Company Details
10.17.2 Kyowa Hakko Kirin Business Overview and Its Total Revenue
10.17.3 Kyowa Hakko Kirin Nanotechnology for Healthcare Introduction
10.17.4 Kyowa Hakko Kirin Revenue in Nanotechnology for Healthcare Business (2015-2020)
10.17.5 Kyowa Hakko Kirin Recent Development
13.18 Shire
10.18.1 Shire Company Details
10.18.2 Shire Business Overview and Its Total Revenue
10.18.3 Shire Nanotechnology for Healthcare Introduction
10.18.4 Shire Revenue in Nanotechnology for Healthcare Business (2015-2020)
10.18.5 Shire Recent Development
13.19 Ipsen
10.19.1 Ipsen Company Details
10.19.2 Ipsen Business Overview and Its Total Revenue
10.19.3 Ipsen Nanotechnology for Healthcare Introduction
10.19.4 Ipsen Revenue in Nanotechnology for Healthcare Business (2015-2020)
10.19.5 Ipsen Recent Development
13.20 Endo International
10.20.1 Endo International Company Details
10.20.2 Endo International Business Overview and Its Total Revenue
10.20.3 Endo International Nanotechnology for Healthcare Introduction
10.20.4 Endo International Revenue in Nanotechnology for Healthcare Business (2015-2020)
10.20.5 Endo International Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Nanotechnology for Healthcare Key Market Segments
Table 2. Key Players Covered: Ranking by Nanotechnology for Healthcare Revenue
Table 3. Ranking of Global Top Nanotechnology for Healthcare Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Nanotechnology for Healthcare Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Nanomedicine
Table 6. Key Players of Nano Medical Devices
Table 7. Key Players of Nano Diagnosis
Table 8. Key Players of Other
Table 9. COVID-19 Impact Global Market: (Four Nanotechnology for Healthcare Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Nanotechnology for Healthcare Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Nanotechnology for Healthcare Players to Combat Covid-19 Impact
Table 14. Global Nanotechnology for Healthcare Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Nanotechnology for Healthcare Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Nanotechnology for Healthcare Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Nanotechnology for Healthcare Market Share by Regions (2015-2020)
Table 18. Global Nanotechnology for Healthcare Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Nanotechnology for Healthcare Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Nanotechnology for Healthcare Market Growth Strategy
Table 24. Main Points Interviewed from Key Nanotechnology for Healthcare Players
Table 25. Global Nanotechnology for Healthcare Revenue by Players (2015-2020) (Million US$)
Table 26. Global Nanotechnology for Healthcare Market Share by Players (2015-2020)
Table 27. Global Top Nanotechnology for Healthcare Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nanotechnology for Healthcare as of 2019)
Table 28. Global Nanotechnology for Healthcare by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Nanotechnology for Healthcare Product Solution and Service
Table 31. Date of Enter into Nanotechnology for Healthcare Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Nanotechnology for Healthcare Market Size by Type (2015-2020) (Million US$)
Table 34. Global Nanotechnology for Healthcare Market Size Share by Type (2015-2020)
Table 35. Global Nanotechnology for Healthcare Revenue Market Share by Type (2021-2026)
Table 36. Global Nanotechnology for Healthcare Market Size Share by Application (2015-2020)
Table 37. Global Nanotechnology for Healthcare Market Size by Application (2015-2020) (Million US$)
Table 38. Global Nanotechnology for Healthcare Market Size Share by Application (2021-2026)
Table 39. North America Key Players Nanotechnology for Healthcare Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Nanotechnology for Healthcare Market Share (2019-2020)
Table 41. North America Nanotechnology for Healthcare Market Size by Type (2015-2020) (Million US$)
Table 42. North America Nanotechnology for Healthcare Market Share by Type (2015-2020)
Table 43. North America Nanotechnology for Healthcare Market Size by Application (2015-2020) (Million US$)
Table 44. North America Nanotechnology for Healthcare Market Share by Application (2015-2020)
Table 45. Europe Key Players Nanotechnology for Healthcare Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Nanotechnology for Healthcare Market Share (2019-2020)
Table 47. Europe Nanotechnology for Healthcare Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Nanotechnology for Healthcare Market Share by Type (2015-2020)
Table 49. Europe Nanotechnology for Healthcare Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Nanotechnology for Healthcare Market Share by Application (2015-2020)
Table 51. China Key Players Nanotechnology for Healthcare Revenue (2019-2020) (Million US$)
Table 52. China Key Players Nanotechnology for Healthcare Market Share (2019-2020)
Table 53. China Nanotechnology for Healthcare Market Size by Type (2015-2020) (Million US$)
Table 54. China Nanotechnology for Healthcare Market Share by Type (2015-2020)
Table 55. China Nanotechnology for Healthcare Market Size by Application (2015-2020) (Million US$)
Table 56. China Nanotechnology for Healthcare Market Share by Application (2015-2020)
Table 57. Japan Key Players Nanotechnology for Healthcare Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Nanotechnology for Healthcare Market Share (2019-2020)
Table 59. Japan Nanotechnology for Healthcare Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Nanotechnology for Healthcare Market Share by Type (2015-2020)
Table 61. Japan Nanotechnology for Healthcare Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Nanotechnology for Healthcare Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Nanotechnology for Healthcare Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Nanotechnology for Healthcare Market Share (2019-2020)
Table 65. Southeast Asia Nanotechnology for Healthcare Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Nanotechnology for Healthcare Market Share by Type (2015-2020)
Table 67. Southeast Asia Nanotechnology for Healthcare Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Nanotechnology for Healthcare Market Share by Application (2015-2020)
Table 69. India Key Players Nanotechnology for Healthcare Revenue (2019-2020) (Million US$)
Table 70. India Key Players Nanotechnology for Healthcare Market Share (2019-2020)
Table 71. India Nanotechnology for Healthcare Market Size by Type (2015-2020) (Million US$)
Table 72. India Nanotechnology for Healthcare Market Share by Type (2015-2020)
Table 73. India Nanotechnology for Healthcare Market Size by Application (2015-2020) (Million US$)
Table 74. India Nanotechnology for Healthcare Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Nanotechnology for Healthcare Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Nanotechnology for Healthcare Market Share (2019-2020)
Table 77. Central & South America Nanotechnology for Healthcare Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Nanotechnology for Healthcare Market Share by Type (2015-2020)
Table 79. Central & South America Nanotechnology for Healthcare Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Nanotechnology for Healthcare Market Share by Application (2015-2020)
Table 81. Amgen Company Details
Table 82. Amgen Business Overview
Table 83. Amgen Product
Table 84. Amgen Revenue in Nanotechnology for Healthcare Business (2015-2020) (Million US$)
Table 85. Amgen Recent Development
Table 86. Teva Pharmaceuticals Company Details
Table 87. Teva Pharmaceuticals Business Overview
Table 88. Teva Pharmaceuticals Product
Table 89. Teva Pharmaceuticals Revenue in Nanotechnology for Healthcare Business (2015-2020) (Million US$)
Table 90. Teva Pharmaceuticals Recent Development
Table 91. Abbott Company Details
Table 92. Abbott Business Overview
Table 93. Abbott Product
Table 94. Abbott Revenue in Nanotechnology for Healthcare Business (2015-2020) (Million US$)
Table 95. Abbott Recent Development
Table 96. UCB Company Details
Table 97. UCB Business Overview
Table 98. UCB Product
Table 99. UCB Revenue in Nanotechnology for Healthcare Business (2015-2020) (Million US$)
Table 100. UCB Recent Development
Table 101. Roche Company Details
Table 102. Roche Business Overview
Table 103. Roche Product
Table 104. Roche Revenue in Nanotechnology for Healthcare Business (2015-2020) (Million US$)
Table 105. Roche Recent Development
Table 106. Celgene Company Details
Table 107. Celgene Business Overview
Table 108. Celgene Product
Table 109. Celgene Revenue in Nanotechnology for Healthcare Business (2015-2020) (Million US$)
Table 110. Celgene Recent Development
Table 111. Sanofi Company Details
Table 112. Sanofi Business Overview
Table 113. Sanofi Product
Table 114. Sanofi Revenue in Nanotechnology for Healthcare Business (2015-2020) (Million US$)
Table 115. Sanofi Recent Development
Table 116. Merck & Co Business Overview
Table 117. Merck & Co Product
Table 118. Merck & Co Company Details
Table 119. Merck & Co Revenue in Nanotechnology for Healthcare Business (2015-2020) (Million US$)
Table 120. Merck & Co Recent Development
Table 121. Biogen Company Details
Table 122. Biogen Business Overview
Table 123. Biogen Product
Table 124. Biogen Revenue in Nanotechnology for Healthcare Business (2015-2020) (Million US$)
Table 125. Biogen Recent Development
Table 126. Stryker Company Details
Table 127. Stryker Business Overview
Table 128. Stryker Product
Table 129. Stryker Revenue in Nanotechnology for Healthcare Business (2015-2020) (Million US$)
Table 130. Stryker Recent Development
Table 131. Gilead Sciences Company Details
Table 132. Gilead Sciences Business Overview
Table 133. Gilead Sciences Product
Table 134. Gilead Sciences Revenue in Nanotechnology for Healthcare Business (2015-2020) (Million US$)
Table 135. Gilead Sciences Recent Development
Table 136. Pfizer Company Details
Table 137. Pfizer Business Overview
Table 138. Pfizer Product
Table 139. Pfizer Revenue in Nanotechnology for Healthcare Business (2015-2020) (Million US$)
Table 140. Pfizer Recent Development
Table 141. 3M Company Company Details
Table 142. 3M Company Business Overview
Table 143. 3M Company Product
Table 144. 3M Company Revenue in Nanotechnology for Healthcare Business (2015-2020) (Million US$)
Table 145. 3M Company Recent Development
Table 146. Johnson & Johnson Company Details
Table 147. Johnson & Johnson Business Overview
Table 148. Johnson & Johnson Product
Table 149. Johnson & Johnson Revenue in Nanotechnology for Healthcare Business (2015-2020) (Million US$)
Table 150. Johnson & Johnson Recent Development
Table 151. Smith & Nephew Company Details
Table 152. Smith & Nephew Business Overview
Table 153. Smith & Nephew Product
Table 154. Smith & Nephew Revenue in Nanotechnology for Healthcare Business (2015-2020) (Million US$)
Table 155. Smith & Nephew Recent Development
Table 156. Leadiant Biosciences Company Details
Table 157. Leadiant Biosciences Business Overview
Table 158. Leadiant Biosciences Product
Table 159. Leadiant Biosciences Revenue in Nanotechnology for Healthcare Business (2015-2020) (Million US$)
Table 160. Leadiant Biosciences Recent Development
Table 161. Kyowa Hakko Kirin Company Details
Table 162. Kyowa Hakko Kirin Business Overview
Table 163. Kyowa Hakko Kirin Product
Table 164. Kyowa Hakko Kirin Revenue in Nanotechnology for Healthcare Business (2015-2020) (Million US$)
Table 165. Kyowa Hakko Kirin Recent Development
Table 166. Shire Company Details
Table 167. Shire Business Overview
Table 168. Shire Product
Table 169. Shire Revenue in Nanotechnology for Healthcare Business (2015-2020) (Million US$)
Table 170. Shire Recent Development
Table 171. Ipsen Company Details
Table 172. Ipsen Business Overview
Table 173. Ipsen Product
Table 174. Ipsen Revenue in Nanotechnology for Healthcare Business (2015-2020) (Million US$)
Table 175. Ipsen Recent Development
Table 176. Endo International Company Details
Table 177. Endo International Business Overview
Table 178. Endo International Product
Table 179. Endo International Revenue in Nanotechnology for Healthcare Business (2015-2020) (Million US$)
Table 180. Endo International Recent Development
Table 181. Research Programs/Design for This Report
Table 182. Key Data Information from Secondary Sources
Table 183. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nanotechnology for Healthcare Market Share by Type: 2020 VS 2026
Figure 2. Nanomedicine Features
Figure 3. Nano Medical Devices Features
Figure 4. Nano Diagnosis Features
Figure 5. Other Features
Figure 6. Global Nanotechnology for Healthcare Market Share by Application: 2020 VS 2026
Figure 7. Anticancer Case Studies
Figure 8. CNS Product Case Studies
Figure 9. Anti-infective Case Studies
Figure 10. Other Case Studies
Figure 11. Nanotechnology for Healthcare Report Years Considered
Figure 12. Global Nanotechnology for Healthcare Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Nanotechnology for Healthcare Market Share by Regions: 2020 VS 2026
Figure 14. Global Nanotechnology for Healthcare Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Nanotechnology for Healthcare Market Share by Players in 2019
Figure 17. Global Top Nanotechnology for Healthcare Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nanotechnology for Healthcare as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Nanotechnology for Healthcare Revenue in 2019
Figure 19. North America Nanotechnology for Healthcare Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Nanotechnology for Healthcare Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Nanotechnology for Healthcare Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Nanotechnology for Healthcare Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Nanotechnology for Healthcare Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Nanotechnology for Healthcare Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Nanotechnology for Healthcare Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Amgen Revenue Growth Rate in Nanotechnology for Healthcare Business (2015-2020)
Figure 28. Teva Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Teva Pharmaceuticals Revenue Growth Rate in Nanotechnology for Healthcare Business (2015-2020)
Figure 30. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Abbott Revenue Growth Rate in Nanotechnology for Healthcare Business (2015-2020)
Figure 32. UCB Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. UCB Revenue Growth Rate in Nanotechnology for Healthcare Business (2015-2020)
Figure 34. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Roche Revenue Growth Rate in Nanotechnology for Healthcare Business (2015-2020)
Figure 36. Celgene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Celgene Revenue Growth Rate in Nanotechnology for Healthcare Business (2015-2020)
Figure 38. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Sanofi Revenue Growth Rate in Nanotechnology for Healthcare Business (2015-2020)
Figure 40. Merck & Co Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Merck & Co Revenue Growth Rate in Nanotechnology for Healthcare Business (2015-2020)
Figure 42. Biogen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Biogen Revenue Growth Rate in Nanotechnology for Healthcare Business (2015-2020)
Figure 44. Stryker Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Stryker Revenue Growth Rate in Nanotechnology for Healthcare Business (2015-2020)
Figure 46. Gilead Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Gilead Sciences Revenue Growth Rate in Nanotechnology for Healthcare Business (2015-2020)
Figure 48. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Pfizer Revenue Growth Rate in Nanotechnology for Healthcare Business (2015-2020)
Figure 50. 3M Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. 3M Company Revenue Growth Rate in Nanotechnology for Healthcare Business (2015-2020)
Figure 52. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Johnson & Johnson Revenue Growth Rate in Nanotechnology for Healthcare Business (2015-2020)
Figure 54. Smith & Nephew Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Smith & Nephew Revenue Growth Rate in Nanotechnology for Healthcare Business (2015-2020)
Figure 56. Leadiant Biosciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Leadiant Biosciences Revenue Growth Rate in Nanotechnology for Healthcare Business (2015-2020)
Figure 58. Kyowa Hakko Kirin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Kyowa Hakko Kirin Revenue Growth Rate in Nanotechnology for Healthcare Business (2015-2020)
Figure 60. Shire Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Shire Revenue Growth Rate in Nanotechnology for Healthcare Business (2015-2020)
Figure 62. Ipsen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Ipsen Revenue Growth Rate in Nanotechnology for Healthcare Business (2015-2020)
Figure 64. Endo International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Endo International Revenue Growth Rate in Nanotechnology for Healthcare Business (2015-2020)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $3900
USD $5850
USD $7800
Offer

Why Us

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.